Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 30, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	577	157	29	35	62	61
Market Cap Growth	306.60%	434.24%	-16.81%	-42.59%	1.75%	-25.71%
Enterprise Value	580	159	27	31	61	76
Last Close Price	0.54	0.15	0.03	0.03	0.06	0.07
PE Ratio	-	7.81	8.26	3.97	12.10	-
PS Ratio	8.24	2.77	0.86	1.10	2.42	3.36
PB Ratio	15.83	2.73	1.01	1.40	3.81	5.68
P/TBV Ratio	15.95	2.74	1.03	1.43	3.92	-
P/FCF Ratio	133.66	-	-	5.88	21.50	-
P/OCF Ratio	103.18	-	8.81	5.43	19.27	-
EV/Sales Ratio	8.28	2.81	0.80	0.96	2.40	4.25
EV/EBITDA Ratio	40.22	13.14	5.25	4.94	17.86	-
EV/EBIT Ratio	47.62	14.75	6.92	6.11	28.90	-
EV/FCF Ratio	134.35	-	-	5.15	21.24	-
Debt / Equity Ratio	0.31	0.20	0.13	0.11	0.15	0.38
Debt / EBITDA Ratio	0.78	0.96	0.73	0.43	0.66	-
Debt / FCF Ratio	2.61	-	-	0.46	0.83	-
Asset Turnover	0.85	0.91	0.90	1.05	0.99	0.73
Inventory Turnover	2.27	2.69	2.16	2.97	2.95	2.31
Quick Ratio	1.82	2.04	1.40	1.73	1.15	0.61
Current Ratio	3.27	3.07	2.75	2.82	2.10	1.19
Return on Equity (ROE)	-43.41%	46.47%	13.15%	43.01%	37.96%	-20.32%
Return on Assets (ROA)	9.20%	10.83%	6.52%	10.33%	5.14%	-5.79%
Return on Capital (ROIC)	14.92%	13.20%	8.15%	13.62%	7.92%	-9.50%
Return on Capital Employed (ROCE)	16.00%	15.30%	12.00%	17.80%	10.30%	-
Earnings Yield	-3.12%	12.80%	12.11%	25.18%	8.27%	-3.70%
FCF Yield	0.75%	-2.60%	-8.15%	17.00%	4.65%	-3.02%
Buyback Yield / Dilution	-3.71%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.